Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew D Howard

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Genomics|May 31, 2002
Melanin-concentrating hormone receptor subtypes 1 and 2: species-specific gene expressionCarina P Tan, Hideki Sano, Hisashi Iwaasa, et al.
Plos One|October 21, 2017
GPR40 partial agonists and AgoPAMs: Differentiating effects on glucose and hormonal secretions in the rodentMichele J Pachanski, Melissa E Kirkland, Daniel T Kosinski, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2017
Corrigendum to "Discovery of benzofuran propanoic acid GPR120 agonists: From uHTS hit to mechanism-based pharmacodynamic effects" [Bioorg. Med. Chem. Lett. 26 (2016) 5724-5728]Matthew Lombardo, Kate Bender, Clare London, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2016
Discovery of benzofuran propanoic acid GPR120 agonists: From uHTS hit to mechanism-based pharmacodynamic effectsMatthew Lombardo, Kate Bender, Clare London, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Structure-Activity Relationship of Novel and Selective Biaryl-Chroman GPR40 AgoPAMsHelen Y Chen, Christopher W Plummer, Dong Xiao, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Design and Synthesis of Novel, Selective GPR40 AgoPAMsChristopher W Plummer, Matthew J Clements, Helen Chen, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2019
Design, synthesis and biological evaluation of indane derived GPR40 agoPAMsBarbara Pio, Harry R Chobanian, Yan Guo, et al.
Journal of Medicinal Chemistry|October 4, 2002
Design and pharmacology of N-[(3R)-1,2,3,4-tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonistIyassu K Sebhat, William J Martin, Zhixiong Ye, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|September 4, 2009
Obesity and genetics regulate microRNAs in islets, liver, and adipose of diabetic miceEnpeng Zhao, Mark P Keller, Mary E Rabaglia, et al.
ACS Medicinal Chemistry Letters|December 21, 2016
Discovery and Optimization of a Novel Triazole Series of GPR142 Agonists for the Treatment of Type 2 DiabetesLiangqin Guo, Dann L Parker, Yi Zang, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Genomics|May 31, 2002
Melanin-concentrating hormone receptor subtypes 1 and 2: species-specific gene expressionCarina P Tan, Hideki Sano, Hisashi Iwaasa, et al.
Plos One|October 21, 2017
GPR40 partial agonists and AgoPAMs: Differentiating effects on glucose and hormonal secretions in the rodentMichele J Pachanski, Melissa E Kirkland, Daniel T Kosinski, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2017
Corrigendum to "Discovery of benzofuran propanoic acid GPR120 agonists: From uHTS hit to mechanism-based pharmacodynamic effects" [Bioorg. Med. Chem. Lett. 26 (2016) 5724-5728]Matthew Lombardo, Kate Bender, Clare London, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2016
Discovery of benzofuran propanoic acid GPR120 agonists: From uHTS hit to mechanism-based pharmacodynamic effectsMatthew Lombardo, Kate Bender, Clare London, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Structure-Activity Relationship of Novel and Selective Biaryl-Chroman GPR40 AgoPAMsHelen Y Chen, Christopher W Plummer, Dong Xiao, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Design and Synthesis of Novel, Selective GPR40 AgoPAMsChristopher W Plummer, Matthew J Clements, Helen Chen, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2019
Design, synthesis and biological evaluation of indane derived GPR40 agoPAMsBarbara Pio, Harry R Chobanian, Yan Guo, et al.
Journal of Medicinal Chemistry|October 4, 2002
Design and pharmacology of N-[(3R)-1,2,3,4-tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonistIyassu K Sebhat, William J Martin, Zhixiong Ye, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|September 4, 2009
Obesity and genetics regulate microRNAs in islets, liver, and adipose of diabetic miceEnpeng Zhao, Mark P Keller, Mary E Rabaglia, et al.
ACS Medicinal Chemistry Letters|December 21, 2016
Discovery and Optimization of a Novel Triazole Series of GPR142 Agonists for the Treatment of Type 2 DiabetesLiangqin Guo, Dann L Parker, Yi Zang, et al.
Pageof 6